Asthma biomarkers and COVID-19 continue to dominate current medical issues.
作者信息
Bellanti Joseph A, Settipane Russell A
出版信息
Allergy Asthma Proc. 2022 Sep 1;43(5):363-367. doi: 10.2500/aap.2022.43.220062.
Abstract
摘要
相似文献
1
Asthma biomarkers and COVID-19 continue to dominate current medical issues.哮喘生物标志物与新冠病毒病仍是当前医学领域的主要议题。
Allergy Asthma Proc. 2022 Sep 1;43(5):363-367. doi: 10.2500/aap.2022.43.220062.
2
[Asthma and COVID-19].[哮喘与2019冠状病毒病]
Rev Alerg Mex. 2022;69 Suppl 1:s15-s23. doi: 10.29262/ram.v69iSupl1.1009.
3
[COVID-19 and asthma control].[新型冠状病毒肺炎与哮喘控制]
Rev Mal Respir. 2021 Jan;38(1):111-113. doi: 10.1016/j.rmr.2020.11.006. Epub 2020 Nov 17.
4
Association between pediatric asthma and positive tests for SARS-CoV-2 in the District of Columbia.哥伦比亚特区儿童哮喘与新冠病毒检测呈阳性之间的关联。
J Allergy Clin Immunol Pract. 2021 Sep;9(9):3490-3493. doi: 10.1016/j.jaip.2021.06.036. Epub 2021 Jul 12.
5
Asthmatic patients and COVID-19: Different disease course?哮喘患者与2019冠状病毒病：病程不同？
Allergy. 2021 Mar;76(3):963-965. doi: 10.1111/all.14601.
6
The Impact of Asthma on Mortality in Patients With COVID-19.哮喘对COVID-19患者死亡率的影响。
Chest. 2020 Dec;158(6):2290-2291. doi: 10.1016/j.chest.2020.05.575. Epub 2020 Jun 6.
7
Coronavirus disease 2019 and asthma, allergic rhinitis: molecular mechanisms and host-environmental interactions.新型冠状病毒病 2019 与哮喘、变应性鼻炎：分子机制与宿主-环境相互作用。
Curr Opin Allergy Clin Immunol. 2021 Feb 1;21(1):1-7. doi: 10.1097/ACI.0000000000000699.
8
Asthma Diagnosis without Aerosol-Generating Procedures (Spirometry): Evidence for and Beyond the COVID-19 Pandemic.无气溶胶生成程序的哮喘诊断（肺功能测定）：COVID-19大流行期间及之后的证据
J Allergy Clin Immunol Pract. 2021 Dec;9(12):4252-4253. doi: 10.1016/j.jaip.2021.09.036.
9
Telemedicine for Asthma Follow-up in Children During COVID-19 Pandemic.2019年冠状病毒病大流行期间儿童哮喘随访的远程医疗
Indian J Pediatr. 2021 Oct;88(10):1050. doi: 10.1007/s12098-021-03868-5. Epub 2021 Jul 28.
10
The evidence is in that asthma is not associated with severe coronavirus disease 2019.有证据表明，哮喘与严重的2019冠状病毒病无关。
Ann Allergy Asthma Immunol. 2021 May;126(5):451-452. doi: 10.1016/j.anai.2021.02.023.
本文引用的文献
1
Capturing total steroid burden in patients with atopic dermatitis and asthma.评估特应性皮炎和哮喘患者的总类固醇负担。
Allergy Asthma Proc. 2022 Sep 1;43(5):454-460. doi: 10.2500/aap.2022.43.220057.
2
Management of pediatric hereditary angioedema types 1 and 2: A search for international consensus.儿童遗传性血管性水肿 1 型和 2 型的管理：寻求国际共识。
Allergy Asthma Proc. 2022 Sep 1;43(5):388-396. doi: 10.2500/aap.2022.43.220052.
3
Longitudinal experience with treatment of acquired angioedema using tranexamic acid.使用氨甲环酸治疗获得性血管性水肿的纵向经验。
Allergy Asthma Proc. 2022 Sep 1;43(5):413-418. doi: 10.2500/aap.2022.43.220043.
4
The diagnostic accuracy of spirometry versus peak expiratory flow test for follow-up of adult asthma patients at primary care level.肺量计与呼气峰流速试验对初级保健水平下成人哮喘患者随访的诊断准确性比较。
Allergy Asthma Proc. 2022 Sep 1;43(5):e58-e64. doi: 10.2500/aap.2022.43.220049.
5
Cat allergy in children and the effect of the COVID-19 pandemic.儿童猫过敏与 COVID-19 大流行的影响。
Allergy Asthma Proc. 2022 Sep 1;43(5):e31-e39. doi: 10.2500/aap.2022.43.220037.
6
Salivary and serum IgA and IgG responses to SARS-CoV-2-spike protein following SARS-CoV-2 infection and after immunization with COVID-19 vaccines.感染 SARS-CoV-2 后和接种 COVID-19 疫苗后针对 SARS-CoV-2 刺突蛋白的唾液和血清 IgA 和 IgG 反应。
Allergy Asthma Proc. 2022 Sep 1;43(5):419-430. doi: 10.2500/aap.2022.43.220045.
7
Dose-dependent association between inhaled corticosteroid use and risk of obesity and metabolic syndrome in asthma.吸入性皮质类固醇的使用与哮喘患者肥胖和代谢综合征风险的剂量相关性。
Allergy Asthma Proc. 2022 Sep 1;43(5):446-453. doi: 10.2500/aap.2022.43.220027.
8
Clinical implications of asthma endotypes and phenotypes.哮喘内型和表型的临床意义。
Allergy Asthma Proc. 2022 Sep 1;43(5):375-382. doi: 10.2500/aap.2022.43.220047.
9
Association between air pollution and the prevalence of allergic rhinitis in Chinese children: A systematic review and meta-analysis.空气污染与中国儿童过敏性鼻炎患病率之间的关联：一项系统评价和荟萃分析。
Allergy Asthma Proc. 2022 Sep 1;43(5):e47-e57. doi: 10.2500/aap.2022.43.220044.
10
Clinical and economic burden of chronic rhinosinusitis with nasal polyposis: A U.S. administrative claims analysis.慢性鼻-鼻窦炎伴鼻息肉的临床和经济负担：美国行政索赔分析。
Allergy Asthma Proc. 2022 Sep 1;43(5):435-445. doi: 10.2500/aap.2022.43.220048.
Zotero 插件